M. Visini

Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group

Emilio Bajetta, Roberto Buzzoni, Luigi Mariani et al. · Annals of Oncology · 2002 · 137 citations

Surgical Oncology, Italian Trials, Gastrointestinal Oncology +8

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial

Karin Ribi, Weixiu Luo, Jürg Bernhard et al. · Journal of Clinical Oncology · 2016 · 123 citations · Full text

A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group

Maria Di Bartolomeo, Emilio Bajetta, Anna Maria Bochicchio et al. · Annals of Oncology · 1995 · 88 citations

Endocrine Oncology, Oncology, Italian Trials +8

Second Line Therapy with Weekly Low-dose Docetaxel for Pretreated Non-Small-Cell Lung Carcinoma Patients: A Multicenter Italian Phase II Study

Antonio Ardizzoia, Mirko Acquati, Daniele Fagnani et al. · Lung · 2004 · 18 citations

Medicine, Weekly Low-dose Docetaxel, Bronchial Neoplasm +8

Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)—first results from PathIES

Valerie Speirs, Giuseppe Viale, Kelly Mousa et al. · Annals of Oncology · 2015 · 13 citations · Full text

Clinical Disorders, Prognostic Evaluation, Disease Progression +8